Camps, C., Sarries, C., Roig, B., Javier Sánchez, J., Queralt, C., Sancho, E., . . . Rosell, R. (2003). Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients. Clinical lung cancer, 4(4), 237-241. https://doi.org/10.3816/CLC.2003.n.004
Citace podle Chicago (17th ed.)Camps, Carlos, Carmen Sarries, Bárbara Roig, José Javier Sánchez, Cristina Queralt, Eva Sancho, Natividad Martinez, Miguel Tarón, a Rafael Rosell. "Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients." Clinical Lung Cancer 4, no. 4 (2003): 237-241. https://doi.org/10.3816/CLC.2003.n.004.
Citace podle MLA (9th ed.)Camps, Carlos, et al. "Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients." Clinical Lung Cancer, vol. 4, no. 4, 2003, pp. 237-241, https://doi.org/10.3816/CLC.2003.n.004.